Sunday 18 October 2026
Export AGMB’s income statement to Excel — free account
AgomAb Therapeutics NV
AGMB
Insiders bought in the last twelve months.
8.28
0.05
−0.60%
Follow AGMB
| Dec '24 | Sep '25 | Dec '25 | Jun '26 | |
|---|---|---|---|---|
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
— | — | — | 0.00 |
Free Cash Flow |
— | — | — | (144.00) |
| Other line items | ||||
Cash ROIC |
0.00% | 0.00% | 0.00% | (23.90%) |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | — | — | 0.00 |
Depreciation/Fixed assets |
0.00 | — | 0.00 | 1.53 |
Capex/Depreciation |
— | — | — | 0.00 |
Operating CF per Share |
— | — | — | 0.00 |
Columns are period end dates